Guardant Health, Inc.
NASDAQ:GH
25.08 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Revenue
| 563.948 | 449.538 | 373.653 | 286.73 | 214.375 | 90.639 | 49.842 | 25.249 |
| Cost of Revenue
| 227.052 | 156.325 | 122.912 | 92.535 | 70.72 | 43.21 | 31.618 | 22.124 |
| Gross Profit
| 336.896 | 293.213 | 250.741 | 194.195 | 143.655 | 47.429 | 18.224 | 3.125 |
| Gross Profit Ratio
| 0.597 | 0.652 | 0.671 | 0.677 | 0.67 | 0.523 | 0.366 | 0.124 |
| Reseach & Development Expenses
| 365.094 | 373.807 | 263.221 | 149.862 | 86.292 | 50.714 | 25.562 | 10.859 |
| General & Administrative Expenses
| 155.8 | 163.956 | 206.64 | 192.77 | 61.399 | 36.192 | 36.777 | 9.921 |
| Selling & Marketing Expenses
| 295.227 | 299.828 | 191.881 | 106.513 | 78.335 | 53.465 | 32.497 | 26.192 |
| SG&A
| 449.817 | 463.784 | 398.521 | 299.283 | 139.734 | 89.657 | 69.274 | 36.113 |
| Other Expenses
| -84.5 | -112.563 | 25.178 | 3.641 | 0.088 | 4.702 | -1.059 | -0.001 |
| Operating Expenses
| 899.411 | 837.591 | 661.742 | 449.145 | 226.026 | 140.371 | 94.836 | 46.972 |
| Operating Income
| -562.515 | -544.378 | -411.001 | -254.95 | -82.371 | -92.942 | -76.612 | -43.847 |
| Operating Income Ratio
| -0.997 | -1.211 | -1.1 | -0.889 | -0.384 | -1.025 | -1.537 | -1.737 |
| Total Other Income Expenses Net
| 83.751 | -109.071 | 26.531 | 9.046 | 12.648 | 4.702 | -6.134 | -0.001 |
| Income Before Tax
| -478.764 | -653.449 | -384.47 | -245.904 | -69.723 | -84.225 | -83.214 | -46.133 |
| Income Before Tax Ratio
| -0.849 | -1.454 | -1.029 | -0.858 | -0.325 | -0.929 | -1.67 | -1.827 |
| Income Tax Expense
| 0.685 | 1.139 | 0.3 | 0.379 | -1.872 | 0.038 | 0.007 | 0.006 |
| Net Income
| -479.449 | -654.588 | -384.77 | -246.283 | -67.851 | -85.063 | -83.221 | -46.139 |
| Net Income Ratio
| -0.85 | -1.456 | -1.03 | -0.859 | -0.317 | -0.938 | -1.67 | -1.827 |
| EPS
| -4.28 | -6.41 | -3.8 | -2.53 | -0.75 | -2.8 | -1.18 | -0.65 |
| EPS Diluted
| -4.28 | -6.41 | -3.8 | -2.53 | -0.75 | -2.8 | -1.18 | -0.65 |
| EBITDA
| -519.634 | -650.872 | -381.893 | -241.138 | -68.542 | -82.974 | -70.231 | -39.422 |
| EBITDA Ratio
| -0.921 | -1.448 | -1.022 | -0.841 | -0.32 | -0.915 | -1.409 | -1.561 |